Search

Search Constraints

You searched for: Author/Creator Shirin, H

Search Results

5. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (14th July 2015)

10. P675 The relationship between gender, severity of disease, treatment type, and employment outcome in patients with inflammatory bowel disease in Israel. (25th January 2019)